Venous lake of the lip treated with a sclerosing agent: Report of two cases

Dermatologic Surgery

Volumn 29, Issue 4, 2003, Pages 425-428

  Kuo, Hung Wen ^a   Yang, Chih Hsun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL; SCLEROSING AGENT;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPRESSION THERAPY; CRYOTHERAPY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LIP; LOW LEVEL LASER THERAPY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCLEROTHERAPY; SIDE EFFECT; SKIN BLOOD VESSEL DISORDER; TREATMENT OUTCOME; VEIN LAKE;

AGED; AGED, 80 AND OVER; DILATATION, PATHOLOGIC; FEMALE; HUMANS; LIP; MALE; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; VEINS;

EID: 0037387188     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29101.x     Document Type: Article

References (16)

1. Bean WB, Walsh JR. Venous lakes. Arch Dermatol 1956;74:459-63.
2. Landthaler M, Haina D, Waidelich W, Braun-Falco O. Laser therapy of venous lakes (Bean-Walsh) and telangiectasias. Plast Reconstr Surg 1984;73:78-83.
3. Bu JQ, Shi HY, Hu M, Liu HC. Oral venous lake: a clinicohistologic analysis of 20 cases. Chin J Stomatol 2002;37:33-5.
4. Alcalay J, Sandbank M. The ultrastructure of cutaneous venous lake. Int J Dermatol 1987;26:645-6.
5. Suhonen R, Kuflik EG. Venous lakes treated by liquid nitrogen cryosurgery. Br J Dermatol 1997;137:1018-9.
6. Jay H, Borek C. Treatment of a venous-lake angioma with intense pulsed light. Lancet 1998;351:112.
7. Colver GB, Hunter GAA. Venous lakes: treatment by infrared coagulation. Br J Plast Surg 1987;40:451-3.
8. Gonzalez E, Gange RW, Momtaz KT. Treatment of telangiectasias and other benign vascular lesions with the 577 nm pulsed dye laser. J Am Acad Dermatol 1992;27:220-6.
9. Neumann RA, Knobler RM. Venous lakes (Bean-Walsh) of the lips: treatment experience with the argon laser and 18 months follow-up. Clin Exp Dermatol 1990;15:115-8.
10. Winter H, Dräger E, Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg 2000;26:105-8.
11. Lorimier AA. Sclerotherapy for venous malformation. J Pediatr Surg 1995;30:188-94.
12. Seccia A, Salgarello M. Treatment of angiomas with sclerosing injection of hydroxypolyethoxydodecan. Angiology 1991;42:23-9.
13. Jakson IT, Carreño R, Potparic Z, Hussain K. Hemangioms, vascular malformation, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 1993;91:1216-30.
14. Weiss RA, Feied CF, Weiss MA. Vein Diagnosis and Treatment: A Comprehensive Approach. New York: McGraw-Hill, 200:126.
15. Goldman MP, Kaplan RP, Oki LN., et al. Sclerosing agents in the treatment of telangiectasia: comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model. Arch Dermatol 1987;123:1196-201.
16. Govrin-Yehudain J, Moscona AR, Calderon N, Hirshowitz B. Treatment of hemangiomas by sclerosing agent: an experimental and clinical study. Ann Plast Surg 1987;18:465-9.